Hormonal Contraception Is Associated with a Reduced Risk of Bacterial Vaginosis: A Systematic Review and Meta-Analysis

Objective To examine the association between hormonal contraception (HC) and bacterial vaginosis (BV) by systematic review and meta-analysis. Methods Medline, Web of Science and Embase databases were searched to 24/1/13 and duplicate references removed. Inclusion criteria 1) >20 BV cases; 2) accepted BV diagnostic method; 3) measure of HC-use either as combined oestrogen-progesterone HC (combined), progesterone-only contraception (POC) or unspecified HC (u-HC); 4) ≥10% of women using HC; 5) analysis of the association between BV and HC-use presented; 6) appropriate control group. Data extracted included: type of HC, BV diagnostic method and outcome (prevalent, incident, recurrent), and geographical and clinic-setting. Meta-analyses were conducted to calculate pooled effect sizes (ES), stratified by HC-type and BV outcome. This systematic review is registered with PROSPERO (CRD42013003699). Results Of 1713 unique references identified, 502 full-text articles were assessed for eligibility and 55 studies met inclusion criteria. Hormonal contraceptive use was associated with a significant reduction in the odds of prevalent BV (pooled effect size by random-effects [reES] = 0.68, 95%CI0.63–0.73), and in the relative risk (RR) of incident (reES = 0.82, 95%CI:0.72–0.92), and recurrent (reES = 0.69, 95%CI:0.59–0.91) BV. When stratified by HC-type, combined-HC and POC were both associated with decreased prevalence of BV and risk of incident BV. In the pooled analysis of the effect of HC-use on the composite outcome of prevalent/incident/recurrent BV, HC-use was associated with a reduced risk of any BV (reES = 0.78, 95%CI:0.74–0.82). Conclusion HC-use was associated with a significantly reduced risk of BV. This negative association was robust and present regardless of HC-type and evident across all three BV outcome measures. When stratified by HC-type, combined-HC and POC were both individually associated with a reduction in the prevalence and incidence of BV. This meta-analysis provides compelling evidence that HC-use influences a woman’s risk of BV, with important implications for clinicians and researchers in the field.

[1]  S. Garland,et al.  Recurrence of bacterial vaginosis is significantly associated with posttreatment sexual activities and hormonal contraceptive use. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2]  Jane S. Hocking,et al.  Prevalent and Incident Bacterial Vaginosis Are Associated with Sexual and Contraceptive Behaviours in Young Australian Women , 2013, PloS one.

[3]  D. Caldeira,et al.  Risk of pneumonia associated with use of angiotensin converting enzyme inhibitors and angiotensin receptor blockers: systematic review and meta-analysis , 2012, BMJ : British Medical Journal.

[4]  A. Fitzpatrick,et al.  Genital Tract Infections, Bacterial Vaginosis, HIV, and Reproductive Health Issues among Lima-Based Clandestine Female Sex Workers , 2012, Infectious diseases in obstetrics and gynecology.

[5]  P. Gajer,et al.  Comparison of Storage Conditions for Human Vaginal Microbiome Studies , 2012, PloS one.

[6]  S. Garland,et al.  Efficacy of Oral Metronidazole with Vaginal Clindamycin or Vaginal Probiotic for Bacterial Vaginosis: Randomised Placebo-Controlled Double-Blind Trial , 2012, PloS one.

[7]  I. Brill,et al.  Bacterial vaginosis, gonorrhea, and chlamydial infection among women attending a sexually transmitted disease clinic: a longitudinal analysis of possible causal links. , 2012, Annals of epidemiology.

[8]  W. Ledger,et al.  Influence of Lactic Acid on Endogenous and Viral RNA-Induced Immune Mediator Production by Vaginal Epithelial Cells , 2011, Obstetrics and gynecology.

[9]  R. Cone,et al.  In vaginal fluid, bacteria associated with bacterial vaginosis can be suppressed with lactic acid but not hydrogen peroxide , 2011, BMC infectious diseases.

[10]  R. Brotman,et al.  A case control study of anovaginal distance and bacterial vaginosis , 2011, International journal of STD & AIDS.

[11]  K. Holmes,et al.  Topical Penile Microbicide Use by Men to Prevent Recurrent Bacterial Vaginosis in Sex Partners: A Randomized Clinical Trial , 2011, Sexually transmitted diseases.

[12]  J. Fahey,et al.  REVIEW ARTICLE: Sex Hormone Regulation of Innate Immunity in the Female Reproductive Tract: The Role of Epithelial Cells in Balancing Reproductive Potential with Protection against Sexually Transmitted Pathogens , 2010, American journal of reproductive immunology.

[13]  R. Cone,et al.  Cervicovaginal fluid and semen block the microbicidal activity of hydrogen peroxide produced by vaginal lactobacilli , 2010, BMC infectious diseases.

[14]  J. Marrazzo,et al.  Temporal Variability of Human Vaginal Bacteria and Relationship with Bacterial Vaginosis , 2010, PloS one.

[15]  R. Brotman,et al.  Race of Male Sex Partners and Occurrence of Bacterial Vaginosis , 2010, Sexually transmitted diseases.

[16]  Z. Hel,et al.  Sex steroid hormones, hormonal contraception, and the immunobiology of human immunodeficiency virus-1 infection. , 2010, Endocrine reviews.

[17]  R. Brotman,et al.  Personal Hygienic Behaviors and Bacterial Vaginosis , 2010, Sexually transmitted diseases.

[18]  J. Hocking,et al.  Early sexual experiences and risk factors for bacterial vaginosis. , 2009, The Journal of infectious diseases.

[19]  I. Kleinschmidt,et al.  Use of injectable progestin contraception and risk of STI among South African women. , 2009, Contraception.

[20]  D. Moher,et al.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement , 2009, BMJ : British Medical Journal.

[21]  R. Anorlu,et al.  The effects of antimicrobial therapy on bacterial vaginosis in non-pregnant women. , 2009, The Cochrane database of systematic reviews.

[22]  C. Benedetto,et al.  Vaginal and endocervical microorganisms in symptomatic and asymptomatic non-pregnant females: risk factors and rates of occurrence. , 2009, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[23]  R. Brotman,et al.  Hormonal contraception and risk of bacterial vaginosis diagnosis in an observational study of women attending STD clinics in Baltimore, MD. , 2009, Contraception.

[24]  J. Changalucha,et al.  Bacterial vaginosis in female facility workers in north-western Tanzania: prevalence and risk factors , 2009, Sexually Transmitted Infections.

[25]  M. Yotebieng,et al.  Effect of consistent condom use on 6‐month prevalence of bacterial vaginosis varies by baseline BV status , 2009, Tropical medicine & international health : TM & IH.

[26]  J. Hocking,et al.  Sexual risk factors and bacterial vaginosis: a systematic review and meta-analysis. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[27]  A. Adimora,et al.  Bacterial vaginosis and HIV acquisition: a meta-analysis of published studies , 2008, AIDS.

[28]  R. Hayes,et al.  Persisting with prevention: The importance of adherence for HIV prevention , 2008, Emerging themes in epidemiology.

[29]  C. Morrison,et al.  Risk Factors for Bacterial Vaginosis Incidence in Young Adult Thai Women , 2008, Sexually transmitted diseases.

[30]  G. Spear,et al.  TLR2-mediated cell stimulation in bacterial vaginosis. , 2008, Journal of reproductive immunology.

[31]  J. Baeten,et al.  A Prospective Study of Risk Factors for Bacterial Vaginosis in HIV-1-Seronegative African Women , 2008, Sexually transmitted diseases.

[32]  J. Peipert,et al.  Bacterial Vaginosis, Race, and Sexually Transmitted Infections: Does Race Modify the Association? , 2008, Sexually transmitted diseases.

[33]  L. Meyn,et al.  A Delicate Balance: Risk Factors for Acquisition of Bacterial Vaginosis Include Sexual Activity, Absence of Hydrogen Peroxide-Producing Lactobacilli, Black Race, and Positive Herpes Simplex Virus Type 2 Serology , 2008, Sexually transmitted diseases.

[34]  M. Klebanoff,et al.  Longitudinal Association Between Hormonal Contraceptives and Bacterial Vaginosis in Women of Reproductive Age , 2007, Sexually transmitted diseases.

[35]  J. Kendrick,et al.  The Prevalence of Bacterial Vaginosis in the United States, 2001–2004; Associations With Symptoms, Sexual Behaviors, and Reproductive Health , 2007, Sexually transmitted diseases.

[36]  A. Gonçalves,et al.  Evaluation of hygienic douching on the vaginal microflora of female sex workers , 2007, International journal of STD & AIDS.

[37]  S. Pocock,et al.  Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies , 2007, BMJ : British Medical Journal.

[38]  R. Straub,et al.  The complex role of estrogens in inflammation. , 2007, Endocrine reviews.

[39]  A. Scally,et al.  Prevalence of bacterial vaginosis in lesbians and heterosexual women in a community setting , 2007, Sexually Transmitted Infections.

[40]  I. Kleinschmidt,et al.  Injectable progestin contraceptive use and risk of HIV infection in a South African family planning cohort. , 2007, Contraception.

[41]  Scott M. Williams,et al.  Association of interleukin-1β and interleukin-1 receptor antagonist polymorphisms with bacterial vaginosis in non-pregnant Italian women , 2007 .

[42]  J. Peipert,et al.  Prevalence of Bacterial Vaginosis: 2001–2004 National Health and Nutrition Examination Survey Data , 2007, Obstetrics and gynecology.

[43]  R. McClelland,et al.  Associations Between Intravaginal Practices and Bacterial Vaginosis in Kenyan Female Sex Workers Without Symptoms of Vaginal Infections , 2006, Sexually transmitted diseases.

[44]  S. Garland,et al.  High recurrence rates of bacterial vaginosis over the course of 12 months after oral metronidazole therapy and factors associated with recurrence. , 2006, The Journal of infectious diseases.

[45]  M. Klebanoff,et al.  The association of psychosocial stress and bacterial vaginosis in a longitudinal cohort. , 2006, American journal of obstetrics and gynecology.

[46]  R. Desmond,et al.  Risk Factors for Bacterial Vaginosis in Women at High Risk for Sexually Transmitted Diseases , 2005, Sexually transmitted diseases.

[47]  Jun Zhang,et al.  Perceived life stress and bacterial vaginosis. , 2005, Journal of women's health.

[48]  R. Garfein,et al.  Prevalence and Correlates of Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis infections, and Bacterial Vaginosis Among a Cohort of Young Injection Drug Users in Baltimore, Maryland , 2005, Sexually transmitted diseases.

[49]  S. Garland,et al.  Higher-Risk Behavioral Practices Associated With Bacterial Vaginosis Compared With Vaginal Candidiasis , 2005, Obstetrics and gynecology.

[50]  L. Morison,et al.  Bacterial vaginosis in relation to menstrual cycle, menstrual protection method, and sexual intercourse in rural Gambian women , 2005, Sexually Transmitted Infections.

[51]  T. Ashraf-Ganjoei.  Risk factors for bacterial vaginosis in women attending a hospital in Kerman, Islamic Republic of Iran. , 2005, Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit.

[52]  O. Kiriwat,et al.  Prevalence of bacterial vaginosis in Thai women attending the family planning clinic, Siriraj Hospital. , 2004, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.

[53]  R. Desmond,et al.  Predictors of Bacterial Vaginosis in Adolescent Women Who Douche , 2004, Sexually transmitted diseases.

[54]  M. Latino,et al.  Sexually transmitted diseases and pelvic inflammatory disease. , 2004, Minerva ginecologica.

[55]  A. Mindel,et al.  Social and sexual risk factors for bacterial vaginosis , 2004, Sexually Transmitted Infections.

[56]  C. Boyer,et al.  Bacterial Vaginosis in Sexually Experienced and Non–Sexually Experienced Young Women Entering the Military , 2003, Obstetrics and gynecology.

[57]  Z. Samra,et al.  Vaginitis in a gynecologic practice in Israel: causes and risk factors. , 2003, The Israel Medical Association journal : IMAJ.

[58]  M. Krohn,et al.  Bacterial vaginosis is a strong predictor of Neisseria gonorrhoeae and Chlamydia trachomatis infection. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[59]  R. Ness,et al.  Can known risk factors explain racial differences in the occurrence of bacterial vaginosis? , 2003, Journal of the National Medical Association.

[60]  V. Hogan,et al.  Indications for therapy and treatment recommendations for bacterial vaginosis in nonpregnant and pregnant women: a synthesis of data. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[61]  R. Ness,et al.  Douching in Relation to Bacterial Vaginosis, Lactobacilli, and Facultative Bacteria in the Vagina , 2002, Obstetrics and gynecology.

[62]  C. Holzman,et al.  Factors linked to bacterial vaginosis in nonpregnant women. , 2001, American journal of public health.

[63]  C. Ryan,et al.  High rate of bacterial vaginosis among women with intrauterine devices in Manado, Indonesia. , 2001, Contraception.

[64]  K. Whaley,et al.  Origins of vaginal acidity: high D/L lactate ratio is consistent with bacteria being the primary source. , 2001, Human reproduction.

[65]  R. Kaul,et al.  Sexually transmitted infections and vaginal douching in a population of female sex workers in Nairobi, Kenya , 2001, Sexually transmitted infections.

[66]  J. Baeten,et al.  Hormonal contraception and risk of sexually transmitted disease acquisition: results from a prospective study. , 2001, American journal of obstetrics and gynecology.

[67]  E. Calzolari,et al.  Bacterial vaginosis and contraceptive methods , 2000, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[68]  I. Brill,et al.  Effectiveness of an intervention promoting the female condom to patients at sexually transmitted disease clinics. , 2000, American journal of public health.

[69]  B. Chohan,et al.  Vaginal lactobacilli, microbial flora, and risk of human immunodeficiency virus type 1 and sexually transmitted disease acquisition. , 1999, The Journal of infectious diseases.

[70]  J. Zenilman,et al.  Bacterial vaginosis is not associated with circumcision status of the current male partner. , 1999, Sexually transmitted infections.

[71]  M. Gigante,et al.  Sexually transmitted diseases and reproductive tract infections among contraceptive users , 1998, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[72]  G. Jarosik,et al.  Acquisition of Iron by Gardnerella vaginalis , 1998, Infection and Immunity.

[73]  D. Hellberg,et al.  Contraceptive use in women with bacterial vaginosis. , 1997, Contraception.

[74]  J. Schwebke,et al.  The Use of Sequential Self‐Obtained Vaginal Smears for Detecting Changes in the Vaginal Flora , 1997, Sexually transmitted diseases.

[75]  Mary Frances Cotch,et al.  Association between Bacterial Vaginosis and Preterm Delivery of a Low-Birth-Weight Infant , 1995 .

[76]  K. Nelson,et al.  Bacterial vaginosis and HIV seroprevalence among female commercial sex workers in Chiang Mai, Thailand , 1995, AIDS.

[77]  D. Taylor-Robinson,et al.  A longitudinal study of bacterial vaginosis during pregnancy , 1994, British journal of obstetrics and gynaecology.

[78]  G. Hart.  Factors Associated with Trichomoniasis, Candidiasis and Bacterial Vaginosis , 1993, International journal of STD & AIDS.

[79]  K. Holmes,et al.  Microbiological, epidemiological and clinical correlates of vaginal colonisation by Mobiluncus species. , 1991, Genitourinary medicine.

[80]  F. Barbone,et al.  A follow-up study of methods of contraception, sexual activity, and rates of trichomoniasis, candidiasis, and bacterial vaginosis. , 1990, American journal of obstetrics and gynecology.

[81]  H. Moi,et al.  Prevalence of Bacterial Vaginosis and its Association with Genital Infections, Inflammation, and Contraceptive Methods in Women Attending Sexually Transmitted Disease and Primary Health Clinics , 1990, International journal of STD & AIDS.

[82]  J. Lefèvre,et al.  Lower Genital Tract Infections in Women: Comparison of Clinical and Epidemiologic Findings with Microbiology , 1988, Sexually transmitted diseases.

[83]  V. Bykerk,et al.  Consensus Statement , 2004, Pediatric Clinical Practice Guidelines & Policies.

[84]  J. Baeten,et al.  Use of hormonal contraceptives and risk of HIV-1 transmission: a prospective cohort study. , 2012, The Lancet. Infectious diseases.

[85]  S. Gelber,et al.  Pregnancy-specific association of vitamin D deficiency and bacterial vaginosis. , 2011, American journal of obstetrics and gynecology.

[86]  S. Zakaria,et al.  Evaluation of BV(®) Blue Test Kit for the diagnosis of bacterial vaginosis. , 2011, Sexual & reproductive healthcare : official journal of the Swedish Association of Midwives.

[87]  R. Edelman,et al.  "Association between Bacterial Vaginosis and Preterm Delivery of a Low- birth-weight Infant." , 1996 .

[88]  K. Holmes,et al.  Nonspecific vaginitis: Diagnostic criteria and microbial and epidemiologic associations , 1983 .

[89]  H. Critchley,et al.  Reproductive Biology and Endocrinology Open Access Innate Immune Defences in the Human Endometrium , 2022 .

[90]  M. F. Rios Grassi,et al.  Clinical Study Prevalence and Risk Factors for Bacterial Vaginosis and Other Vulvovaginitis in a Population of Sexually Active Adolescents from Salvador, Bahia, Brazil , 2022 .